Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Equity (Tables)

v3.8.0.1
Equity (Tables)
12 Months Ended
Dec. 31, 2017
Schedule of Stock Option Activity

A summary of the stock option activity for the year ended December 31, 2017 is as follows:

      Weighted Average
Number of Options Exercise Price
Options outstanding as of December 31, 2016                   2,615,461 $ 37.21
Granted 2,139,698 20.41
Exercised (604,536 ) 10.84
Forfeited (819,670 ) 35.89
Options outstanding as of December 31, 2017 3,330,953 $ 31.53
Options exercisable as of December 31, 2017 1,109,094 $ 49.68
Schedule of Stock Options Outstanding

The following table summarizes information about stock options outstanding at December 31, 2017:

Options Outstanding Options Exercisable
            Outstanding     Weighted- Average         Exercisable    
options at Remaining Weighted- Average options at Weighted- Average
Range of December 31, Contractual Exercise December 31, Exercise
Exercise Prices 2017 Life in Years Price 2017 Price
$ 2.74 - $ 9.32 14,539 4.08 $ 6.77 $ 14,536 $ 6.77
$    19.66 - $ 19.66 1,351,385 8.94 19.66 30,339 19.66
$ 19.96 - $ 24.66 887,398 8.57 21.94 282,367 22.55
$ 27.83 - $    120.51 1,077,631 5.52 54.59 781,852 61.45
3,330,953 $ 7.71 $ 31.53 1,109,094 $ 49.68
   
Aggregate intrinsic value (U.S. $ in thousands) $ 597 $ 201
Summary of RSUs activity

A summary of the Company’s RSUs activity for the year ended December 31, 2017 is as follows:

      Weighted Average
Number of RSUs Grant Date Fair
Unvested RSUs outstanding as of December 31, 2016 267,756 $ 72.17
Granted 278,514 20.18
Vested                 (130,884 ) 75.09
Forfeited (113,223 ) 51.10
Unvested RSUs outstanding as of December 31, 2017 302,163 $ 30.88
Schedule of Equity classified stock-based compensation

Stock-based compensation expense for stock options and equity classified RSUs included in the Company’s Statements of Operations were allocated as follows:

2017       2016       2015
(U.S. $ in thousands)
Cost of sales $ 2,580 $ 2,780 $ 5,381
Research and development, net 3,503 4,768 5,759
Selling, general and administrative 11,639 13,225 18,870
Total stock-based compensation expenses $      17,722 $      20,773 $      30,010
Schedule of Accumulated other comprehensive income (loss)

The following tables present the changes in the components of accumulated other comprehensive loss, net of taxes for the years ended December 31, 2017, 2016 and 2015:

Year ended December 31, 2017
Net unrealized gain       Foreign currency      
(loss) on cash flow translation
hedges adjustments Total
U.S. $ in thousands
Balance as of January 1, 2017 $ (24 ) $ (13,455 ) $        (13,479 )
Other comprehensive loss before reclassifications 1,315 5,834 7,149
Amounts reclassified from accumulated other comprehensive loss (961 ) 268 (693 )
Other comprehensive income (loss) 354 6,102 6,456
Balance as of December 31, 2017 $ 330 $ (7,353 ) $ (7,023 )

Year ended December 31, 2016
      Net unrealized gain       Foreign currency      
(loss) on cash flow translation
hedges adjustments Total
U.S. $ in thousands
Balance as of January 1, 2016 $ (107 ) $ (10,667 ) $ (10,774 )
Other comprehensive loss before reclassifications 523 (2,788 ) (2,265 )
Amounts reclassified from accumulated other comprehensive loss (440 ) - (440 )
Other comprehensive income (loss) 83 (2,788 ) (2,705 )
Balance as of December 31, 2016 $ (24 ) $ (13,455 ) $ (13,479 )
 
Year ended December 31, 2015
Net unrealized gain Foreign currency
(loss) on cash flow translation
hedges adjustments Total
U.S. $ in thousands
Balance as of January 1, 2015 $ (1,243 ) $ (2,404 ) $ (3,647 )
Other comprehensive loss before reclassifications (288 ) (8,263 ) $ (8,551 )
Amounts reclassified from accumulated other comprehensive loss 1,424 - $ 1,424
Other comprehensive income (loss)                         1,136 (8,263 ) (7,127 )
Balance as of December 31, 2015 $ (107 ) $                  (10,667 ) $       (10,774 )
Employee Stock Option [Member]  
Schedule of Stock Option Assumptions

The Company used the Black-Scholes option-pricing model to determine the fair value of options granted during 2017, 2016 and 2015. The following assumptions were applied in determining the options’ fair value on their grant date:

2017       2016       2015
Risk-free interest rate 1.8%-2.2% 1.1%-1.5% 1.6% - 1.9%
Expected option term (years) 5.1-6.0 5.2-6.0 6
Expected share price volatility 52.6%-54.0% 53.6%-56.1% 50.1%-53.5%
Dividend yield - - -
Weighted average grant date fair value $ 11.10 $ 12.36 $ 15.49